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Cancer chemotherapy for outpatients to the patients with head and neck squamous cell
carcinoma －conbination therapy of carboplatin and UFT－
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University of Tokushima School of Medicine, Tokushima, Japan
SUMMARY
We practiced the combination therapy of carboplatin (CBDCA) and UFT for the patients with
head and neck cancer. It was given to 5 patients for adjuvant after first line therapy and also given
3 patients with recurrrence. CBDCA (450mg/body) was given i.v. at day 1, and UFT (400mg/day)
was given p.o. from day 7 to day 28 repeatedly. The result was that 2 patients were obtained NC.
The side effects of more than grade 3 were observed in 2 patients, whose AUC were calculated
over 5, retrospectively. The combination therapy with CBDCA and UFT that can be given to out-
patients may be useful for adjuvant chemotherapy or salvage chemotherapy to increase the quality
of life.
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